Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting (CINV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06904235
What this trial is testing

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA 95
Not applicableStudy completedNCT01344304
What this trial is testing

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Who this might be right for
Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 413
Post-approval studies (Phase 4)Study completedNCT04054193
What this trial is testing

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 103
Early research (Phase 1)WithdrawnNCT01596413
What this trial is testing

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Kyowa Kirin Pharmaceutical Development Ltd
Large-scale testing (Phase 3)Study completedNCT06007586
What this trial is testing

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Who this might be right for
Gynecological TumorOvarian CancerCervical Cancer+2 more
Sichuan Cancer Hospital and Research Institute 143
Early research (Phase 1)WithdrawnNCT01596426
What this trial is testing

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Kyowa Kirin Pharmaceutical Development Ltd
Large-scale testing (Phase 3)Study completedNCT01594749
What this trial is testing

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 1,015
Testing effectiveness (Phase 2)WithdrawnNCT04085393
What this trial is testing

Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT03862144
What this trial is testing

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech 150
Large-scale testing (Phase 3)Study completedNCT00273468
What this trial is testing

To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Kyowa Kirin Co., Ltd. 630
Large-scale testing (Phase 3)Study completedNCT01500226
What this trial is testing

Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 1,369
Testing effectiveness (Phase 2)Ended earlyNCT00895245
What this trial is testing

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Nausea and VomitingStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+8 more
University of Washington 6
Large-scale testing (Phase 3)Study completedNCT01499849
What this trial is testing

Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 532
Large-scale testing (Phase 3)Not Yet RecruitingNCT07761325
What this trial is testing

Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Breast CancerAromatherapyChemotherapy+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 374
Large-scale testing (Phase 3)Study completedNCT06331520
What this trial is testing

NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

Who this might be right for
Chemotherapy-induced Nausea and VomitingHighly Emetogenic Chemotherapy
Fudan University 644
Post-approval studies (Phase 4)UnknownNCT05434663
What this trial is testing

Safety Study of Repeat Doses of SUSTOL in Adults

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Heron Therapeutics 300
Post-approval studies (Phase 4)Study completedNCT04817189
What this trial is testing

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 414
Not applicableStudy completedNCT01490060
What this trial is testing

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Who this might be right for
SarcomaChemotherapy-induced Nausea and VomitingEffects of Chemotherapy+1 more
M.D. Anderson Cancer Center 47
Not applicableEnrolling By InvitationNCT07747194
What this trial is testing

Acupuncture to Prevent Nausea and Vomiting After Stem Cell Transplant

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)Hematopoietic Stem Cell Transplantation (HSCT)
Xiao Wang 80
Post-approval studies (Phase 4)UnknownNCT01662687
What this trial is testing

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Who this might be right for
Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
LG Life Sciences 276
Next Page